COVID-19 Vaccine, mRNA | B125742 | BioNTech Manufacturing GmbH
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Aug. 23, 2033 | Active | Computed |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12324833(composition) · relevance 60/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
3 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.